| Patients will experience prompt relief of lesions within one to two days of initializing treatment with dapsone or sulfapyridine. |
|
| Skin lesions in linear IgA dermatosis and chronic bullous disease of childhood respond rapidly when treated with dapsone or sulfapyridine. |
|
| Additional regimens include alternative dosing schedules of dapsone or inhaled pentamidine isethionate. |
|
| The sulfone antibiotic dapsone often is recommended, although no prospective trials support its use for bites in humans. |
|
| Prophylaxis with trimethoprim-sulfamethoxazole or dapsone plus pyrimethamine is recommended. |
|
| Chemotherapy for leprosy generally includes dapsone, rifampicin and clofazimine, which themselves may affect genetic damage in treated leprosy patients. |
|
| In milder cases of bullous pemphigoid, other antiinflammatory medications such as dapsone and tetracyclines have proven effective. |
|
| The patient was started on dapsone 100 mg daily, rifampin 600 mg monthly, clofazimine 50 mg daily, and clofazimine 300 mg monthly for 12 months. |
|
| Upon presentation, the patient was also on a prophylactic antibiotic regimen consisting of dapsone and azithromycin. |
|
| Amikacin, imipenem, third-generation cephalosporins, minocycline, and dapsone are alternative treatment agents. |
|
| In the 1960s and 1970s chemoprophylaxis with dapsone and acedapsone was investigated. |
|
| The leprosy control program in Brazil distributes free dapsone, rifampin, and clofazimine as part of the World Health Organization multidrug regimen for treatment of leprosy. |
|
| Topical therapy with a corticosteroid is indicated as the initial treatment for mild cases of cicatricial pemphigoid, and dapsone can be used for recurrences. |
|
